Bio-Rad Laboratories (BIO)
245.80 +13.51 (+5.82%) 04/11/25 [NYSE]
N/A x N/A 445.00 x 100
Realtime by (Cboe BZX)
N/A x N/A 445.00 x 100
Realtime 245.80 unch (unch) 04/11/25
for Fri, Apr 11th, 2025
Results
download Want to compare other data? Select Fields| Symbol | BIO | LNTH | PBH | ||
| Company | Bio-Rad Laboratories | Lantheus Holdings | Prestige Brand Holdings | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NYSE | ||
| Open | 235.04 | 98.51 | 80.88 | ||
| High | 246.11 | 102.27 | 82.32 | ||
| Low | 231.72 | 96.00 | 79.98 | ||
| Last | 245.80 | 102.00 | 82.12 | ||
| Change | +13.51 | +3.49 | +1.41 | ||
| % Change | +5.82% | +3.54% | +1.75% | ||
| Volume | 362,800 | 732,100 | 358,400 | ||
| 20-Day Average Volume | 468,860 | 814,555 | 414,970 | ||
| Previous Close | 232.29 | 98.51 | 80.71 | ||
| Industry | Medical Products | Medical Products | Medical Products | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 244.42 | 98.31 | 84.00 | ||
| 20-Day Raw Stochastic | 67.54% | 89.52% | 41.00% | ||
| 20-Day Relative Strength | 45.10% | 56.02% | 46.95% | ||
| Weighted Alpha | -26.30 | +21.52 | +19.66 | ||
| Today's Opinion | 88% Sell | 56% Buy | 24% Buy | ||
| Previous Opinion | 100% Sell | 56% Buy | 40% Buy | ||
| Last Month's Opinion | 88% Sell | Hold | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +8.95% since 04/04/25 | +12.19% since 04/04/25 | -0.88% since 04/04/25 | ||
| Low | 215.38 on 04/07/25 | 85.00 on 04/07/25 | 77.65 on 04/09/25 | ||
| High | 249.58 on 04/09/25 | 102.27 on 04/11/25 | 84.24 on 04/09/25 | ||
| 1-Month | |||||
| %Chg | -2.08% since 03/11/25 | -2.50% since 03/11/25 | -3.49% since 03/11/25 | ||
| Low | 215.38 on 04/07/25 | 85.00 on 04/07/25 | 77.65 on 04/09/25 | ||
| High | 260.42 on 03/18/25 | 105.67 on 03/12/25 | 88.54 on 04/01/25 | ||
| 3-Month | |||||
| %Chg | -28.08% since 01/10/25 | +6.38% since 01/10/25 | +10.97% since 01/10/25 | ||
| Low | 215.38 on 04/07/25 | 77.73 on 02/24/25 | 73.48 on 01/13/25 | ||
| High | 373.69 on 01/28/25 | 111.29 on 03/11/25 | 90.04 on 03/10/25 | ||
| 6-Month | |||||
| %Chg | -27.04% since 10/11/24 | -9.08% since 10/11/24 | +18.02% since 10/11/24 | ||
| Low | 215.38 on 04/07/25 | 75.00 on 11/19/24 | 69.49 on 10/14/24 | ||
| High | 387.99 on 11/06/24 | 118.21 on 11/04/24 | 90.04 on 03/10/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,885,101 | 6,984,961 | 4,068,060 | ||
| Shares Outstanding, K | 28,011 | 68,480 | 49,538 | ||
| Annual Sales | 2,566,500,000 | 1,533,910,000 | 1,125,360,000 | ||
| Annual Net Income | -1,844,200,000 | 312,440,000 | 209,340,000 | ||
| Last Quarter Sales | 667,470,000 | 391,110,000 | 290,320,000 | ||
| Last Quarter Net Income | -715,800,000 | -11,790,000 | 61,030,000 | ||
| 60-Month Beta | 1.12 | 0.20 | 0.47 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 2.90 on 02/13/25 | 1.59 on 02/26/25 | 1.22 on 02/06/25 | ||
| Latest Earnings Date | 05/06/25 | 05/01/25 | 05/08/25 | ||
| Most Recent Dividend | N/A | N/A | 0.475 on 09/27/18 | ||
| Next Ex-Dividends Date | N/A | N/A | 09/27/18 | ||
| Ratios | |||||
| Price/Earnings ttm | 22.53 | 16.58 | 19.08 | ||